Information Provided By: 
Fly News Breaks for January 10, 2017
OPK, NTRA
Jan 10, 2017 | 09:56 EDT
Piper Jaffray analyst William Quirk said Natera's (NTRA) termination of a distribution agreement with Bio-Reference Laboratories, which has been acquired by OPKO Health (OPK), is a positive for Natera as the company has many payer contracts in place and has successfully transitioned a series of physicians to a direct model in the past. Natera will now directly market Panorama to clinicians as well as market Horizon to them, which Bio-Reference had not previously done, said Quirk, who keeps an Overweight rating on Natera shares.
News For NTRA;OPK From the Last 2 Days
There are no results for your query NTRA;OPK
